Am. J. Respir. Crit. Care Med., Volume 162, Number 5, November 2000, 1925-1931

Neutrophil-Mediated Degradation of Lung Proteoglycans
Stimulation by Tumor Necrosis Factor- in Sputum of Patients with Bronchiectasis

DAISY K. Y. SHUM, STANLEY C. H. CHAN, and MARY S. M. IP

Departments of Biochemistry and Medicine, Faculty of Medicine, University of Hong Kong, Hong Kong, China

Neutrophil-mediated degradation of bronchial matrix has been proposed as a pathogenetic factor in bronchiectasis. We hypothesize that neutrophils, found in abundance in the bronchial lumens of patients with bronchiectasis, are capable of degrading lung matrix proteoglycans and that proinflammatory mediators in bronchial secretions of these patients can enhance the degradative action of neutrophils. We used rat bronchoalveolar proteoglycans entrapped in polyacrylamide gel beads as a substrate for test incubations with neutrophils from healthy volunteers and sputum sol from patients with idiopathic bronchiectasis. Coincubations with specimens of sputum sol and neutrophils showed proteoglycan degradation indices (PDIs) in excess of the sum of indices due to incubation with either heat-inactivated sputum sol or heat-inactivated neutrophils, suggesting sputum stimulation of the neutrophil response. Mediation of this stimulation by tumor necrosis factor (TNF)- was suggested because (1) indices for the coincubations correlated with sputum levels of TNF- and (2) an anti-TNF- antibody completely attenuated the sputum-stimulated effect. Furthermore, recombinant human TNF- required accompanying sputum sol to exert an enhancing effect on neutrophil-mediated proteoglycan degradation. Because neutrophil-mediated proteoglycan degradation in the coincubations was inhibited largely (90%) by Eglin C and much less so (8% to 20%) by ethylenediamine tetraacetic acid, we conclude that serine proteases secreted by neutrophils were mainly responsible for degradation of proteoglycans in the model matrix and that the secretion was stimulated by TNF- in the presence of cofactors in the bronchial secretions of patients with bronchiectasis.

This article has been cited by other articles:

				S. Fuschillo, A. De Felice, and G. Balzano Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Eur. Respir. J., February 1, 2008; 31(2): 396 - 406. [Abstract] [Full Text] [PDF]

				P. J. Dubin and J. K. Kolls IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L519 - L528. [Abstract] [Full Text] [PDF]

				M. J. Rosen Chronic Cough Due to Bronchiectasis: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 122S - 131S. [Abstract] [Full Text] [PDF]

				N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF]

				A P Watt, V Brown, J Courtney, M Kelly, L Garske, J S Elborn, and M Ennis Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis Thorax, March 1, 2004; 59(3): 231 - 236. [Abstract] [Full Text] [PDF]

				S. C. H. Chan, D. K. Y. Shum, and M. S. M. Ip Sputum Sol Neutrophil Elastase Activity in Bronchiectasis: Differential Modulation by Syndecan-1 Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 192 - 198. [Abstract] [Full Text] [PDF]

				F. Sabounchi-Schutt, J. Astrom, U. Hellman, A. Eklund, and J. Grunewald Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach Eur. Respir. J., March 1, 2003; 21(3): 414 - 420. [Abstract] [Full Text] [PDF]

				A. F. Barker Bronchiectasis N. Engl. J. Med., May 2, 2002; 346(18): 1383 - 1393. [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]